Pfizer
Beth Begier is a highly experienced public health professional with extensive expertise in epidemiology and vaccine development. Currently serving as Senior Director in Global Medical Affairs at Pfizer, Beth has held various leadership roles focused on scientific affairs for vaccines, particularly in adult RSV, pneumococcal and Lyme diseases. Previous experience includes positions as Director of Epidemiology at Novartis and Assistant Commissioner at the New York City Department of Health and Mental Hygiene. Additionally, Beth has contributed to the Centers for Disease Control and Prevention as an Epidemic Intelligence Service Officer and worked with the FDA on vaccine safety surveillance. Educational credentials include degrees in Medicine and Public Health from recognized institutions, complemented by a residency in Preventive Medicine.
This person is not in any teams
This person is not in any offices
Pfizer
616 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.